{"id":"https://openalex.org/A5080975640","orcid":"https://orcid.org/0000-0001-5363-4590","observed_orcids":["https://orcid.org/0000-0001-5363-4590"],"display_name":"Niklas Peter","raw_author_names":["N. Peter","Niklas Peter"],"full_name":"Niklas Peter","works_count":4,"cited_by_count":25,"summary_stats":{"2yr_mean_citedness":2.5,"h_index":3,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5080975640","orcid":"https://orcid.org/0000-0001-5363-4590","observed_orcids":["https://orcid.org/0000-0001-5363-4590"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210107087","ror":"https://ror.org/01q8f6705","display_name":"BASF (Germany)","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210107087"]},"years":[2025]},{"institution":{"id":"https://openalex.org/I89864525","ror":"https://ror.org/02778hg05","display_name":"Universit\u00e4t Trier","country_code":"DE","type":"education","lineage":["https://openalex.org/I89864525"]},"years":[2026,2023,2020]}],"last_known_institutions":[{"id":"https://openalex.org/I89864525","ror":"https://ror.org/02778hg05","display_name":"Universit\u00e4t Trier","country_code":"DE","type":"education","lineage":["https://openalex.org/I89864525"]}],"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","count":3,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","count":3,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","count":3,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":1,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","count":1,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","value":1.5e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","value":1.27e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","value":9.6e-06,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13840","display_name":"Chemical Safety and Risk Management","value":9e-06,"subfield":{"id":"https://openalex.org/subfields/1504","display_name":"Chemical Health and Safety"},"field":{"id":"https://openalex.org/fields/15","display_name":"Chemical Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","value":6.2e-06,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.762535810470581},{"id":"207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","score":0.6548813581466675},{"id":"202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","score":0.6233999729156494},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.26510000228881836},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.26080000400543213}],"counts_by_year":[{"year":2020,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":2},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":5},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":10}],"display_name_alternatives":["N. Peter","Niklas Peter"],"block_key":"n peter","works_api_url":"https://api.openalex.org/works?filter=author.id:A5080975640","awards_count":0,"updated_date":"2026-11-07T12:08:38","created_date":"2020-11-23T00:00:00"}